Events

Reflotron® GPT 의 리콜

L’Agence nationale de sécurité du médicament et des produits de santé (ANSM)에 따르면, 해당 리콜 는 France 에서 Roche Diagnostics 에 의해 제조된 제품과 관련되어 있습니다.

이것은 무엇인가요?

의료기기에 문제가 생겼을 경우 제조사가 이를 바로잡거나 시장에서 회수하는 조치를 말한다. 회수(Recall)는 의료기기에 결함이 있거나, 건강에 위협이 되거나, 또는 결함도 있고 건강에도 위협이 될 경우에 발생한다.

데이터에 대해 더 자세히 알아보기 여기
  • 사례 유형
    Recall
  • 날짜
    2004-11-04
  • 사례 국가
    France
  • 사례 출처
    ANSM
  • 사례 출처 URL
    https://ansm.sante.fr/S-informer/Informations-de-securite-Retraits-de-lots-et-de-produits/retrait-d-un-lot-du-dmdiv-reflotron-gpt-de-roche-diagnostics
  • 비고 / 경고
    French data is current through early September 2018. All of the data comes from L’Agence nationale de sécurité du médicament et des produits de santé (ANSM), except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and France.
  • 데이터 추가 비고
  • 조치
    On October 20, 2004, Roche Diagnostics informed Afssaps of a withdrawal from the market of batch 23717731 (per 31.12.05) of the in vitro diagnostic medical device called Reflotron® GPT - reference 10745138, produced on October 12, 2004 , following the demonstration by the control laboratory of the supplier, of an anomaly of certain strips leading to the obtaining of erroneous results. The company Roche Diagnostics has directly informed the recipients of the offending lot by means of the attached message (20/10/2004) (7 KB) (not validated by Afssaps). This message is addressed to the directors of establishments health directors, laboratory directors and reactovigilance correspondents for dissemination, where appropriate, to the services concerned.

Device

Reflotron® GPT
  • 모델명 / 제조번호(시리얼번호)
  • 제품 설명
    in-vitro_medical_device
  • Manufacturer
    Roche Diagnostics

Manufacturer

Roche Diagnostics